Early-stage, indolent, non-Hodgkin lymphoma (stages 1 and 2)
Localised radiotherapy alone is used to treat patients with early stage or indolent non-Hodgkin lymphoma. This is generally very successful.
Late-stage, indolent, non-Hodgkin lymphoma (stages 3 and 4)
At first many patient may be managed with a ‘watch and wait’ approach
After this they will receive a mixture of chemotherapy drugs as well as some radiotherapy.
Relapsed indolent non-Hodgkin lymphoma
Additional chemotherapy is used to treat patients with indolent non-Hodgkin lymphoma that has recurred
Early-stage aggressive non-Hodgkin lymphoma
Patients are treated with several courses of a mixture of chemotherapy drugs.
This limits the chance that patients will develop resistance to any of the drugs and also reduces the side effects.
This may be followed by radiotherapy directed at the affected lymph nodes.
Late-stage aggressive non-Hodgkin lymphoma
Patients are also treated with several courses of chemotherapy drugs
Monoclonal antibody therapy, which targets cancer cells directly, may be used in combination with chemotherapy.
Relapsed aggressive non-Hodgkin lymphoma
Additional high dose chemotherapy is used to treat patients with aggressive non-Hodgkin lymphoma whose disease has returned even after having completed treatment.
Some patient may benefit from a stem cell transplant